Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The answer is

There are probably thousands of shareholders and onlookers who have no access to Pacer and also do not follow Agoracom. they see a lower OP to buy in assuming the Court won't make decision until the 19th. Take care

Share
New Message
Please login to post a reply